Product	Form / Strength	Country	Reg. Number	Status
BANDERM TOPICAL None	-	South Africa	29/20.1.6/0537	Registered
BRAVITEX 10 mg Vortioxetine Hydrobromide equivalent to Vortioxetine	-	South Africa	60/1.2/0076	Registered
BRAVITEX 15 mg Vortioxetine Hydrobromide equivalent to Vortioxetine	-	South Africa	60/1.2/0077	Registered
BRAVITEX 20 mg Vortioxetine Hydrobromide equivalent to Vortioxetine	-	South Africa	60/1.2/0078	Registered
BRAVITEX 5 mg Vortioxetine Hydrobromide equivalent to Vortioxetine	-	South Africa	60/1.2/0075	Registered
BRILLIOR 150 mg None	-	South Africa	45/2.5/0838	Canceled
BRILLIOR 25 mg None	-	South Africa	45/2.5/0836	Canceled
BRILLIOR 75 mg None	-	South Africa	45/2.5/0837	Canceled
CAPLIN 2 g/250 mg None	-	South Africa	42/20.1.1/0694	Registered
CAPLIN 4 g/500 mg None	-	South Africa	42/20.1.1/0695	Registered
CARDIBLOK None	-	South Africa	28/5.2/0029	Registered
CECOXELA 100 mg Celecoxib	-	South Africa	45/3.1/0902	Registered
CECOXELA 200 mg Celecoxib	-	South Africa	45/3.1/0903	Registered
CELECOXIB 100 mg VIATRIS None	-	South Africa	45/3.1/0898	Canceled
CELECOXIB 200 mg VIATRIS None	-	South Africa	45/3.1/0899	Canceled
CIPROGEN IV None	-	South Africa	A40/20.1.1/0618	Registered
CLAMENTIN 375 None	-	South Africa	29/20.1.2/0542	Registered
CLAMENTIN S None	-	South Africa	29/20.1.2/0540	Registered
CLAMENTIN SF None	-	South Africa	29/20.1.2/0541	Registered
CLAmgEN IV 0,6 None	-	South Africa	42/20.1.2/0212	Registered

Prev 1 2 3 4 ... 14 Next

261 products